Persistent decline in renal function seen after first stone case November 28, 2016By Keith Loria“Our research shows that the implications of kidney stones may go beyond the discomfort they are so often associated with,” says co-lead author Andrew Rule, MD.
In this issue
Is 1.5 the new magic number for PSA screening? November 28, 2016By Keith LoriaA new approach to prostate cancer screening has been proposed by investigators who claim the idea of informed decision-making by primary care physicians is not working when it comes to PSA testing. USPSTF reform: Will lame-duck Congress act? December 01, 2016By Bob GattyOver the past several months leading up to the November presidential and congressional elections, organizations representing urology sought to persuade members of Congress to bring sense and reason to the U.S. Preventive Services Task Force (USPSTF), which nearly 5 years ago gave a “D” rating to PSA-based screening for prostate cancer. Uro Pipeline: Data from mUC combination therapy suggests efficacy, safety December 01, 2016By Ben SchwartzOther pipeline developments discussed include a bladder cancer test, a male infertility assay, and the first oral dosage treatment for hypogonadism. Study: Patients taking aspirin can safely undergo PCNL December 01, 2016By Wayne KuznarPercutaneous nephrolithotomy in the presence of aspirin appears both effective and safe. In a retrospective review of almost 300 PCNL cases, postoperative hemorrhage was uncommon in patients who continued aspirin preoperatively, said Brandon Otto, MD, at the AUA annual meeting in San Diego. Final rule: Good news, bad news for urologists December 01, 2016By Robert A. Dowling MDIn this article, I outline what urologists should know about major provisions in the 2017 Medicare Physician Fee Schedule and how it may impact their bottom line. Estate planning: Don’t make these mistakesHere is a list of potential estate-planning mistakes you can help avoid with professional counseling. Study: CT urogram leads to costly follow-up imaging December 01, 2016By Randy DotingaFindings from an initial cost analysis support further research and reconsideration of the role of computed tomography urography for imaging evaluation in patients with asymptomatic microhematuria, according to urologists from the University of Alabama at Birmingham. Few prostate Ca patients with BCR develop metastasis December 01, 2016By Wayne KuznarFewer than 20% of patients with biochemical recurrence after radical prostatectomy develop metastasis, and a smaller proportion die as a result of prostate cancer. Mathematical model may predict PCa tumor growth, evolution December 05, 2016By Lisette HiltonThe novel tool could result in earlier prostate cancer diagnoses and less invasive testing, although a prostate cancer expert cautioned that the model makes multiple assumptions and has not been validated. Nomogram helps predict biochemical failure risk post RP December 05, 2016By Lisette HiltonUse of the nomogram, along with factors such as PSA level and family history, is a reliable, useful tool for helping urologists and their patients make better treatment decisions, says the author of a recent study. Polycythemia risk evaluated in patients on TRT pellets December 06, 2016By Keith LoriaResearchers evaluated mean hematocrit before and after pellet implantation in a cohort of 97 patients. Aerobic exercise boosts testosterone levels December 06, 2016By Keith LoriaOverweight and obese men who participated in 12 weeks of aerobic exercise saw significantly increased testosterone levels, a recent study found. High-grade bladder Ca: New data improve risk stratification“We need to identify those patients with high-grade T1 bladder cancer that are likely to recur or progress… and find additional options to prevent recurrence and progression in these patients,” said Joaquim Bellmunt, MD, PhD, in a presentation at the SUO annual meeting. RCC: Multiple pathways provide therapeutic targetsRead highlights from a presentation by Toni K. Choueiri, MD, at the Society of Urologic Oncology annual meeting. MACRA leaves urologists confused, skeptical December 12, 2016By Richard R. KerrThe era of value-based health care has arrived. And while the idea of basing reimbursement on quality and efficiency rather than volume of care is good in theory, the majority of urologists say it will be difficult to carry out, according to Urology Times' 2016 State of the Specialty survey. Top apps for urologists December 13, 2016By Benjamin P. SaylorFrom AUA guidelines to a prostate cancer risk calculator, here are some useful apps recommended by urologists. Top 10 prostate cancer articles of 2016
December 13, 2016These are Urology Times' most-read prostate cancer articles of 2016.
Study examines link between inflammation, prostate Ca December 13, 2016By Keith LoriaResearchers at UCLA have discovered a previously unrecognized type of progenitor cell in inflamed areas of the prostate that have the ability to initiate cancer in response to genetic changes. How will health care change under a Trump presidency? December 14, 2016By Karen Nash"I don’t know what to expect from any aspect of the President Trump camp. There is so much vagueness in what he says," one urologist said. How Trump will change health care: UT’s board members weigh in
December 19, 2016“I am concerned about decreased federal support impacting urologic clinical practices and research progress,” Arthur L. Burnett, II, MD, MBA, told Urology Times.
Top 5 malpractice articles of 2016
December 15, 2016Discussion of cases involving alleged delay in testis cancer diagnosis, bowel perforation during robotic radical prostatectomy, and arterial injury during nephrectomy were among the most read “Malpractice Consult” articles from 2016.
MUSIC: How statewide initiative is improving care, outcomes December 01, 2016By Stephen Y. Nakada MDIn this interview, Khurshid R. Ghani, MD, and David C. Miller, MD, MPH, discuss the origins of the Michigan Urological Surgery Improvement Collaborative, what it’s done for prostate cancer care in Michigan, and how a similar model could be rolled out nationally. New study supports MET for larger ureteric stones December 21, 2016By Keith LoriaA recent review of medical literature adds to the debate surrounding medical expulsive therapy for stone disease.